Long-term ART Does Not Lower Anogenital Cancer Risk in People with HIV

This report highlights that despite immune restoration from long-term antiretroviral therapy (ART), people living with HIV still experience a significantly elevated risk of anogenital cancers including cervical, vulvar, anal, and penile malignancies. The findings underscore ongoing cancer risks in this population despite effective HIV treatment.

Originally published by gnews